FDA forthcoming on heparin investigation
The Food and Drug Administration's (FDA) announcement that the toxin in heparin is over-sulfated chondroitin sulfate demonstrated unusual efficiency by the agency
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.